A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial Assessing Efficacy, Safety, Dose-response of Quinagolide Vaginal Rings Administered Sequentially for 8 Menstrual Cycles in Women With Moderate-Severe Endometriosis-related Pain
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2019
At a glance
- Drugs Quinagolide (Primary)
- Indications Endometriosis; Pain
- Focus Therapeutic Use
- Acronyms RAQUEL
- Sponsors Ferring Pharmaceuticals
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.
- 02 Nov 2018 Planned initiation date changed from 1 Oct 2018 to 1 Dec 2018.
- 10 Oct 2018 New trial record